Wan-Shan Chen - 09 Apr 2026 Form 4 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship: Director
Issuer ticker: BLTE
Reported as of: 09 Apr 2026
Net transaction value: -$198,473
SEC form: 4
Accepted by SEC: 13 Apr 2026, 16:15:08 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Wan-Shan Chen

Key filing fact

Wan-Shan Chen filed Form 4 for BELITE BIO, INC (BLTE) on 13 Apr 2026.

Key facts

This page summarizes Wan-Shan Chen's Form 4 filing for BELITE BIO, INC (BLTE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Apr 2026, 16:15.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: -$198,473.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002001438 Primary reporting owner

Chen Wan-Shan

Relationship: Director
Address: 12750 HIGH BLUFF DRIVE, SUITE 475, SAN DIEGO
Signature: /s/ Wan-Shan Chen
Signature date: 13 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE transaction

American depositary share

Sale

Transaction value: $198,473
Shares: -1,100
Change %: -11%
Price: $180.43
Shares after: 9,096
Date: 09 Apr 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.

Footnote F2

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025.